Navigation Links
AllograftPossibilities.org Meets Unmet Need for Consumer-Oriented Information on Tissue Donation, Transplantation on the Internet
Date:7/28/2011

CENTENNIAL, Colo., July 28, 2011 /PRNewswire/ -- AllograftPossibilities.org has rapidly grown into the premier source for straightforward information on tissue donation and transplant on the web. Although it has the same life-saving and life-enhancing benefits of organ donation, tissue donation is still lesser understood by the general public. The nonprofit AlloSource, a leading developer, processor, and distributor of bone and soft-tissue allografts for use in surgical procedures around the world, created the educational website, AllograftPossibilities.org, to fill an unmet need for consumer information about tissue donation and transplantation on the internet.

Tissue donation rates are lower than organ donation rates and AlloSource found that there was not an online resource dedicated to talking about the benefits of tissue transplantation. The company wanted to honor donor families and encourage others to be both organ and tissue donors by presenting straightforward case studies and medical information on tissue transplant procedures. The easy-to-access online source provides interactive opportunities to ask questions, share stories and connect with others. The website has also become a valued source of information for organ procurement organizations, which work with families throughout the donation process and coordinate transplants.  

"Patients presented with the option of a tissue transplant had few places to go beyond their surgeon to get information. As many people are now consumers of online information, we wanted to create a place that these patients could go to have their questions answered and to read about the donation process and surgical outcomes," said Thomas Cycyota, AlloSource President and CEO. "Encouraging donation and honoring donors is a cornerstone of AlloSource's mission and this site is a tribute to those who make our jobs possible."

In less than two years, the website has already generated impressive web traffic for such a niche topic. It has received more than 10,000 page views and other key indicators for growth also look positive: number of visits, time spent on the site, bounce rate and percentage of new visitors in year two have all beat those from year one.

Key accomplishments of the website include:

  • Promotes tissue donation and honors families touched by the donation process
  • Helps potential patients learn more about the donation side of allograft transplant surgery and better understand the potential surgical outcomes
  • Brings to life the stories of tissue donation by publishing case studies from recipients and donor families
  • Quickly provides expert answers to incoming questions from the public
  • Shares consumer news on updates about medical advancements related to tissue transplantation
  • Provides organ procurement organizations with resources that can be easily downloaded, printed or emailed to assist in their interactions with donor families or in their event and marketing efforts
  • Shares the medical perspective on tissue transplantation to help readers understand how doctors of various specialties utilize allograft tissue
  • Provides a forum for people touched by tissue donation or transplantation to share their stories publicly
  • Promotes donation events throughout the country

For more information, visit: www.allograftpossibilities.org.

About AlloSource

AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has grown into one of the largest tissue networks in the country with more than 350 employees.  It is the world's largest processor of live cellular bone growth substitutes and delivers unparalleled expertise and customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations.   As one of the leading innovators in maximizing tissue donation with the goal of offering optimal solutions for healthcare providers and their patients, AlloSource is recognized by the medical community for its ability to process and provide high quality tissue.   The company is accredited by the American Association of Tissue Banks (AATB) and is headquartered in Centennial, CO. For more information, please visit allosource.org and allograftpossibilities.org.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Thomas Cycyota

http://www.profnetconnect.com/thomas_cycyota


'/>"/>
SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
2. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
5. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
6. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
7. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
8. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
9. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
10. Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
11. Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
Breaking Biology Technology:
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
Breaking Biology News(10 mins):